Cargando…
Magnesium isoglycyrrhizinate suppresses bladder cancer progression by modulating the miR-26b/Nox4 axis
Magnesium isoglycyrrhizinate (MI), a magnesium salt of 18α-GA stereoisomer, has been reported to exert efficient hepatoprotective activity. However, its effect on bladder cancer remains unclear. The study explored the effects of MI on the growth, colony formation, apoptosis, invasion, and migration...
Autores principales: | Yuan, Zhihao, Guo, Guancheng, Sun, Guifang, Li, Qi, Wang, Lihui, Qiao, Baoping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9161837/ https://www.ncbi.nlm.nih.gov/pubmed/35293283 http://dx.doi.org/10.1080/21655979.2022.2031677 |
Ejemplares similares
-
Protective Effect of Magnesium Isoglycyrrhizinate on Ethanol-Induced Testicular Injuries in Mice
por: He, Yuanqiao, et al.
Publicado: (2010) -
Magnesium Isoglycyrrhizinate Reduces Hepatic Lipotoxicity through Regulating Metabolic Abnormalities
por: Lu, Li, et al.
Publicado: (2021) -
Magnesium isoglycyrrhizinate has hepatoprotective effects in an oxaliplatin-induced model of liver injury
por: Zou, Xueqing, et al.
Publicado: (2018) -
Magnesium isoglycyrrhizinate prevents the nonalcoholic hepatic steatosis via regulating energy homeostasis
por: Jiang, Wenjiao, et al.
Publicado: (2020) -
Magnesium isoglycyrrhizinate inhibits airway inflammation in rats with chronic obstructive pulmonary disease
por: Yang, Ye, et al.
Publicado: (2021)